摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

苯胺,3,4,5-三甲氧基-N-甲基- | 124346-71-0

中文名称
苯胺,3,4,5-三甲氧基-N-甲基-
中文别名
——
英文名称
3,4,5-trimethoxy-N-methylaniline
英文别名
N-methyl-3,4,5-trimethoxyaniline
苯胺,3,4,5-三甲氧基-N-甲基-化学式
CAS
124346-71-0
化学式
C10H15NO3
mdl
MFCD11151350
分子量
197.234
InChiKey
XBSMHLZMLQNTLY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    氯仿(微溶)、乙酸乙酯(微溶)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    39.7
  • 氢给体数:
    1
  • 氢受体数:
    4

SDS

SDS:99eb82aa85a09cf8ac867d5e894146e4
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    苯胺,3,4,5-三甲氧基-N-甲基-溶剂黄146 、 sodium nitrite 作用下, 生成 4,10-dihydro-6,7,8-trimethoxy-10-methyl-4-oxo-2-phenylbenzo[g]pteridin-5-oxide
    参考文献:
    名称:
    Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents
    摘要:
    Novel 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides were prepared as a new class of antitumor agents and showed significant antitumor activities against NCI-H 460, HCT 116, A 431, CCRF-HSB-2, and KB cell lines. In vivo investigation, 2-deoxo-10-methyl-2-phenyl-5-deazaflavin exhibited the effective antitumor activity against A 431 human adenocarcinoma cells transplanted subcutaneously into nude mouse. Furthermore, AutoDock study has been done by binding of the flavin analogs into PTK pp60(c-src), where a good correlation between their IC50 and AutoDock binding free energy was exhibited. In particular, 2-deoxo-2-phenylflavin-5-oxides exhibited the highest potential binding affinity within the binding pocket of PTK. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.09.063
  • 作为产物:
    参考文献:
    名称:
    PYRIMIDINE DERIVATIVES AS 5HT2C RECEPTOR ANTAGONISTS
    摘要:
    公开号:
    EP0856001B1
点击查看最新优质反应信息

文献信息

  • INHIBITORS OF MICROBIALLY INDUCED AMYLOID
    申请人:Axial Biotherapeutics, Inc.
    公开号:US20200290970A1
    公开(公告)日:2020-09-17
    The present disclosure provides compounds useful for the prevention of amyloid formation and the treatment of amyloid related disorders, including synucleopathies such as Parkinson's Disease.
    本公开提供了用于预防淀粉样蛋白形成和治疗与淀粉样蛋白相关疾病的化合物,包括如帕金森病这样的突触核蛋白病。
  • Synthesis, Skeletal Rearrangement, and Biological Activities of Spirooxindoles: Exploration of a Stepwise<i>C</i>-Piancatelli Rearrangement
    作者:Li Huang、Xiaoyu Zhang、Jing Li、Ke Ding、Xuehui Li、Wenxu Zheng、Biaolin Yin
    DOI:10.1002/ejoc.201301238
    日期:2014.1
    spiro[thieno-oxindoles] were rearranged under acidic conditions into thieno[2,3-c]quinolin-4-ones, involving an interesting dienone–phenol-like mechanism. The transformation of 2-furylcarbinols into spiro[pentenone-oxindoles] seems to be the first stepwise C-Piancatelli rearrangement. The spirooxindole products were biologically evaluated, and some of them showed promising cytotoxic activities against DU145 and
    在我们先前研究的基础上,研究了2-呋喃基甲醇转化为螺呋喃吲哚的范围,以及螺[呋喃-羟吲哚]和螺[噻吩-羟吲哚]的骨架重排。螺[呋喃-羟吲哚]通过涉及4π-电子系统的旋转电环化的机制热重排成螺[戊烯酮-羟吲哚]。计算电环化步骤的自由能以解释立体化学结果。相比之下,spiro[thieno-oxindoles] 在酸性条件下重排为 thieno[2,3-c] quinolin-4-ones,涉及有趣的二烯酮-苯酚样机制。2-呋喃基甲醇转化为螺[戊烯酮-羟吲哚] 似乎是第一个逐步的 C-Piancatelli 重排。对螺环吲哚产品进行了生物学评价,
  • 4-SUBSTITUTED COUMARIN DERIVATIVES AND PREPARATION METHODS AND USES THEREOF
    申请人:CHEN Lijuan
    公开号:US20180282315A1
    公开(公告)日:2018-10-04
    The present invention pertains to the field of chemical medicine, particularly to 4-substituted coumarin derivatives and preparation methods and applications thereof. The invention provides 4-substituted coumarin derivatives with a structural formula as shown in Formula I. The invention also provides preparation methods and applications for the above 4-substituted coumarin derivatives. The compounds provided in the invention have strong anti-tumor activity with IC50 for plural tumor cell lines between 0.01-5 nM, and it also performs better to inhibit microtubule polymerization and has diversified biological activities and low toxicity, providing new options for drug-sensitive and drug-resistant tumor cells.
    本发明涉及化学药品领域,特别是4-取代香豆素衍生物及其制备方法和应用。该发明提供了具有如公式I所示结构式的4-取代香豆素衍生物。该发明还提供了上述4-取代香豆素衍生物的制备方法和应用。本发明提供的化合物在多种肿瘤细胞系中具有强大的抗肿瘤活性,IC50在0.01-5 nM之间,并且在抑制微管聚合方面表现更好,具有多样化的生物活性和低毒性,为药物敏感和耐药肿瘤细胞提供了新选择。
  • Rh-catalyzed aerobic oxidative cyclization of anilines, alkynes, and CO
    作者:Xinyao Li、Jun Pan、Hao Wu、Ning Jiao
    DOI:10.1039/c7sc02181j
    日期:——
    Transition-metal-catalyzed oxidative C-H cyclization of anilines has been an attractive and powerful strategy for the efficient construction of N-heterocycles. However, the primary and tertiary anilines are rarely employed in this strategy due to the relatively unstability with strong oxidants or the presence of three C-N bonds. By using aerobic oxidative protocol, we describe here a novel Rh-catalyzed
    苯胺的过渡金属催化的氧化 CH 环化已成为有效构建 N-杂环的有吸引力且有效的策略。然而,由于与强氧化剂相对不稳定或存在三个CN键,伯苯胺和叔苯胺很少用于该策略。通过使用有氧氧化协议,我们在这里描述了一种新颖的 Rh 催化 CH 环化各种苯胺与炔烃和 CO。特别是,简单的伯苯胺和通过 CN 键裂解容易制备的叔苯胺可以很容易地转化为 quinolin-2 (1H)-ones,它们是高附加值、具有生物学意义的 N-杂环化合物。
  • [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2015061518A1
    公开(公告)日:2015-04-30
    Compounds of Formula I with activity against HIV, including pharmaceutical compositions and methods for using these compounds in treating human immunodeficiency virus (HIV) infection, are set forth: Formula :(I)
    具有抗艾滋病毒活性的I类化合物,包括用于治疗人类免疫缺陷病毒(HIV)感染的药物组合物和使用这些化合物的方法,如下所示:Formula :(I)
查看更多